Immunic, Inc. (IMUX) NASDAQ
13.05
+0.75(+6.10%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
13.05
+0.75(+6.10%)
Currency In USD
| Market Cap | 83.14M |
| Enterprise Value | 68.34M |
| P/E Ratio | -3.77 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.6 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.55 |
| Return On Equity | -2.21 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -103.06M |
| Net Income | -97.17M |
| Diluted EPS | -6.24 |
| Total Cash | 186.63M |
| Total Cash/Share | 6.19 |
| Total Debt | 421,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.92 |
| Book Value Per Share | 5.02 |
| 52-Week Change | 46.63 |
| 52-Week High | 15.1 |
| 52-Week Low | 5.06 |
| Moving Average 50 Days | 11.27 |
| Moving Average 200 Days | 8.78 |
| Average Volume | 298,231 |
| Shares Outstanding | 9.87M |
| % Held by Institutions | 3.72 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | April 27, 2026 |